Clinical Trial Update: Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and immunogenicity of a prime-boost vaccination strategy for SARS-CoV-2 in patients with cancer; current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Patients With Cancer, Vaccine Reaction | Phase 1, Phase 2 | Status: UNKNOWN